SCHEMBL6131754

SCHEMBL6131754

CCCCCCCC=C(CC)CC

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EP300 Q09472 1/20 0.52
TSHR P16473 3/20 0.46
THRB P10828 1/20 0.42
FAAH O00519 3/20 0.41
TRPV1 Q8NER1 1/20 0.41
TERT O14746 3/20 0.40
MAPT P10636 2/20 0.40
BLM P54132 2/20 0.40
HSD17B10 Q99714 2/20 0.40
FABP4 P15090 2/20 0.40
PTPN1 P18031 2/20 0.40
PPARG P37231 2/20 0.40
PPARD Q03181 2/20 0.40
PPARA Q07869 2/20 0.40
GMNN O75496 1/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
POLB P06746 1/20 0.40
CYP2C9 P11712 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5605179 1.00 EP300 (0.52) EP300TSHRTHRBFAAHTRPV1
SCHEMBL28222807 1.00 EP300 (0.52) EP300TSHRTHRBFAAHTRPV1
SCHEMBL11972786 1.00 EP300 (0.52) EP300TSHRTHRBFAAHTRPV1
SCHEMBL6140916 1.00 EP300 (0.52) EP300TSHRTHRBFAAHTRPV1
SCHEMBL11053878 0.97 EP300 (0.48) EP300TSHRTHRBFAAHTRPV1
SCHEMBL73242 0.89 TSHR (0.41) EP300TSHRTHRBHSD17B10LMNA
SCHEMBL11972938 0.88 EP300 (0.47) EP300TSHRFAAHTERTMAPT
SCHEMBL28499196 0.88 EP300 (0.47) EP300FAAHTERTMAPTBLM
SCHEMBL9018790 0.88 EP300 (0.47) EP300FAAHTERTMAPTBLM
SCHEMBL9131157 0.88 EP300 (0.47) EP300TSHRFAAHTERTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1635984-A Improved process for preparing surfactant alcohols and surfactant alcohol ethers, products prepared by the process and uses thereof BASF AG (DE) 2005-07-06 CN disclosed
US-20050107628-A1 Modified method for producing surfactant alcohols and surfactant alcohol ethers, the products of said method and use of the same BASF AKTIENGESELLSCHAFT (DE) 2005-05-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050107628-A1 Modified method for producing surfactant alcohols and surfactant alcohol ethers, the products of said method and use of the same SGMS1, SGMS2, DEGS1 EP300 1169/4885TSHR 2759/4885THRB 3759/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.